{"name":"NuMe Health","slug":"nume-health","ticker":"","exchange":"","domain":"","description":"NuMe Health is a biotechnology company focused on developing innovative treatments for gastrointestinal disorders. The company's lead candidate, NM504, is currently in Phase 1 clinical trials.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxNOHZRUEJMLVR1Y3AtcmVGTktqMGE4VDdKYkc0NWhqOWQ1UnVvRGZqd3ZnX0stZjNGWnJlUUhNOFd6MmVyd1BOOUU3MTFWZC1HTllyclpicEFiSkJSclhYRFAyTDVzY0JTekpJRTg1X1RxN25CUTBIdElLckV1MVhUdWxCc25YOHlIQTNLNEhCSXdnelk?oc=5","date":"2011-11-01","type":"pipeline","source":"Pharmaceutical Technology","summary":"New Orleans BioInnovation Center - Pharmaceutical Technology","headline":"New Orleans BioInnovation Center","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}